EGFR and glioblastoma: The epidermal growth factor receptor variant III (EGFRvIII) is the most common EGFR mutation occurring in approximately 25–64% of GBM cases; it derives from the in-frame deletion of exons 2–7 of the EGFR gene and codes for a constitutively active, oncogenic, ligand-independent receptor.